Increased cerebrospinal fluid cAMP levels in Alzheimer's disease |
| |
Authors: | Marcos Martí nez, Estrella Fern ndez, Ana Frank, Carmen Guaza, M nica de la Fuente,Angel Hernanz |
| |
Affiliation: | Department of Pathology, Hospital Universitario La Paz, Madrid, Spain. |
| |
Abstract: | Since increasing evidence suggests that upregulation of the cAMP-second messenger system may be implicated in Alzheimer's disease neurodegeneration, we have compared the cAMP and cGMP levels in cerebrospinal fluid (CSF) from patients with dementia of the Alzheimer type (DAT, n=10) with those from nondemented age-matched controls (n=10). Our results show that cAMP levels, but not cGMP, are significantly (p<0.01) elevated in CSF from patients with DAT compared to those from nondemented controls. Moreover, a linear regression analysis demonstrated a significant correlation (r=0.62; p<0.01) between cAMP and tau protein levels in CSF when controls and patients with DAT were studied together. These results suggest that upregulation of cAMP-signaling pathway is implicated in Alzheimer's disease physiopathology. |
| |
Keywords: | cAMP cGMP Tau protein Cerebrospinal fluid Alzheimer's disease |
本文献已被 ScienceDirect 等数据库收录! |
|